Ru Bryan
Works at
Sources: reporter.nih.gov
Grants and prizes
National Institute of Arthritis and Musculoskeletal and Skin Diseases
R41, Development of Nicotinamide-Riboside plus Pterostilbene as a Disease Modifying Osteoarthritis Therapeutic, R41AR082748, 2023–2026, May 26, 2023
US Department of Veterans Affairs
I01, ATP-Citrate Lyase As A Novel Metabolic Target for Osteoarthritis, I01BX002234, 2014–2022, Oct 28, 2021
Sources: reporter.nih.gov